Trendlines Medical makes maiden investment in medical device startup

SINGAPORE (Oct 16): Trendlines Medical Singapore, a 76.43%-owned subsidiary of Catalist-listed Israeli company The Trendlines Group, has made its first investment by committing a total of US$60,000 ($81,150) to a medical device start-up, InterVaal.

InterVaal is developing a urological catheter to address catheter associated urinary tract infection.

Trendlines says that its in-house innovation unit, Trendlines Labs, will work with InterVaal’s Singapore-based staff to develop the catheter and conduct clinical trials in Singapore.

---

Related Stories

• US and allies launch airstrikes on Houthi targets across Yemen
• Trendlines expects US$25 mil to US$30 mil loss for FY2023 in profit warning
• Sarine reverses into the red in 3Q; launches equal access share buyback

---